These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 3908501

  • 1. Antihypertensive effect of carteolol in thiazide-treated hypertensive subjects.
    Velasquez MT, Byrne D, Hoffmann RG.
    J Clin Pharmacol; 1985; 25(8):601-6. PubMed ID: 3908501
    [Abstract] [Full Text] [Related]

  • 2. Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity.
    Giles TD, Sander GE, Roffidal L, Thomas MG, Mersch DP, Moyer RR, Burris JF, Mroczek WJ, Brachfeld J.
    Arch Intern Med; 1988 Aug; 148(8):1725-8. PubMed ID: 3041936
    [Abstract] [Full Text] [Related]

  • 3. Time-dependent antihypertensive effect of carteolol--a beta-adrenoceptor antagonist with partial agonist activity.
    Giles TD, Sander GE, Kaneish A, Quiroz AC.
    Clin Pharmacol Ther; 1984 Mar; 35(3):301-6. PubMed ID: 6697637
    [Abstract] [Full Text] [Related]

  • 4. [Clinical experiences with carteolol in patients with essential hypertension].
    Viehmann P.
    Arzneimittelforschung; 1983 Mar; 33(2a):322-5. PubMed ID: 6340701
    [Abstract] [Full Text] [Related]

  • 5. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS, Lucas CP, Gantt CL, Poland MP, Medakovic M.
    Am J Med; 1983 Oct 17; 75(4A):81-6. PubMed ID: 6356902
    [Abstract] [Full Text] [Related]

  • 6. A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.
    Tarkiainen A, Saraste K, Seppälä T, Gordin A, Auvinen J.
    Eur J Clin Pharmacol; 1981 Mar 17; 19(4):239-44. PubMed ID: 6116605
    [No Abstract] [Full Text] [Related]

  • 7. [Hypotensive effect of carteolol in patients with essential hypertension].
    Beythien RD.
    Arzneimittelforschung; 1983 Mar 17; 33(2a):330-3. PubMed ID: 6682325
    [Abstract] [Full Text] [Related]

  • 8. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
    Schoenberger JA, Glasser SP, Ram CV, McMahon SG, Vanov SK, Leibowitz DA.
    J Cardiovasc Pharmacol; 1984 Mar 17; 6 Suppl 7():S1105-8. PubMed ID: 6085376
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep 17; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan 17; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 11. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL, Pêgo M, Contreras EM, Anglada MP, Martínez JO, Esquerra EA, Sagastagoitia Gorostiza JD, Iberian Multicenter Imidapril Study on Hypertension.
    Clin Ther; 2006 Dec 17; 28(12):2040-51. PubMed ID: 17296460
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R, Reggi DR, Plesher MM, Saini RK, Battikha JP.
    Am J Hypertens; 1996 Apr 17; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [Abstract] [Full Text] [Related]

  • 13. Carteolol treatment of essential hypertension: a long-term study of safety and efficacy.
    Luther RR, Maurath CJ, Klepper MJ, Peckinpaugh RO, Ringham GL.
    J Int Med Res; 1986 Apr 17; 14(4):175-84. PubMed ID: 3758467
    [Abstract] [Full Text] [Related]

  • 14. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L, van der Does R, Hörrmann M, Machwirth M.
    Eur J Clin Pharmacol; 1990 Apr 17; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP, Durier P, Bussiere JL, Gayet JL.
    Eur J Clin Pharmacol; 1990 Apr 17; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [Abstract] [Full Text] [Related]

  • 16. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov 17; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of essential hypertension with the beta-receptor antagonist carteolol. A multicenter study].
    Rosprich G, Sölter H.
    Arzneimittelforschung; 1983 Nov 17; 33(2a):334-9. PubMed ID: 6682326
    [No Abstract] [Full Text] [Related]

  • 18. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb 17; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul 17; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
    Djian J, Roy M, Forette B, Lekieffre J, Luccioni R.
    J Cardiovasc Pharmacol; 1990 Jul 17; 16 Suppl 1():S51-5. PubMed ID: 1706015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.